Pacific Edge shares fall 63% after Novitas decision

Pacific Edge shares fall 63% after Novitas decision
(Image: Pacific Edge)
Rebecca Howard
Cancer diagnostics company Pacific Edge has come out swinging against a decision by Novitas, the Medicare administrative contractor with jurisdiction for its US laboratory, that would end reimbursement for Cxbladder Triage, Detect and Monitor. The shares fell 63% to $0.050 in early trading Monday after a trading halt was lifted.According to Pacific Edge, Novitas continues to misunderstand the current standard of care in evaluating hematuria patients, fails to consider new peer-reviewed evidence and repeats its flawed analysis of the existi...

More Markets

NZX lifts 0.2% as markets wait for US Fed decision
Markets Market Close

NZX lifts 0.2% as markets wait for US Fed decision

The S&P/NZX 50 gained 0.2% to 13,234.89 points on Tuesday.

Gregor Thompson 16 Sep 2025
Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025
New structure, powers for ComCom
Markets

New structure, powers for ComCom

Groceries, aviation, building supplies, digital services carparking all get a mention.

Pattrick Smellie 16 Sep 2025
NZME shareholder Jim Grenon lifts investment in media firm
Markets

NZME shareholder Jim Grenon lifts investment in media firm

NZME shareholder and director Jim Grenon has lifted his investment in the media business for the second time in recent weeks, to just under 18%.A notice to the NZX on Monday stated Grenon had lifted his shareholding from 15.963% to 17.932%, after acquiring 3.7 million shares for...

Staff reporters 16 Sep 2025